'Trojan Horse' agent halts bone metastasis in mice
15th Nov 2006, 07:02 GMT
A novel vascular targeting agent completely prevented the development of bone tumors in 50 percent of the mice tested in a preclinical study, providing early evidence that it could treat, or thwart, growth of tumors in bone, a common destination for a number of cancers when they start to spread.
'Trojan Horse' agent halts bone metastasis in mice related news:
- Hacker who targeted teens sentenced to 10 years in prison — Hack In The Box
- Single-Dose Drug-Loaded Dendrimer Cures Mice of Colon Cancer — PhysOrg.com - latest science and technology news
- Trojan-Spy.Win32.Delf.je — Latest Virus Descriptions
- Stem cells give hope for diabetes cure — NewKerala Health News
- New genetic test predicts risk of metastasis in patients with deadly eye cancer — EurekAlert! - Biology
- Trojan.Win32.Patched.e — Latest Virus Descriptions
- Invasive Micropapillary Carcinoma of the Breast: Association of Pathologic Features With Lymph Node Metastasis — Medscape Pathology Headlines
- Trojan-Downloader.Win32.Small.crd — Latest Virus Descriptions
- Deadly ghost of Agent Orange still lurks — The Seattle Times: Horse racing
- Backdoor.Win32.Agent.lw — Latest Virus Descriptions
Latest news from EurekAlert! - Cancer:
- Targeted cancer drugs may work by disrupting balance of cellular signals
- Studies examine colorectal cancer screening rates
- Higher red meat intake may increase risk for certain breast cancers
- U-M researchers use nanoparticles to target brain cancer
- Increased patient demand for prostate test has serious implications for cancer services
- Novel regulatory mechanism identified for key tumor suppressor p53